01 10McCarthy Tétrault LLP
02 25Merck Canada Inc.
01 112450740
02 112529400
03 112536251
04 22733795
01 8ERTUGLIFLOZIN | SITAGLIPTIN PHOSPHATE
02 9sitagliptin phosphate monohydrate
03 18sitagliptin phosphate monohydrate | metformin hydrochloride
01 8TABLET
02 9TABLET (EXTENDED-RELEASE)
03 12Tablet
04 6Tablets
01 112022-07-05
02 112024-06-18
03 112024-08-27
04 22029-08-17
Patent Expiration Date : 2022-07-05
Date Granted : 2006-02-14
sitagliptin phosphate monohydrate
Brand Name : JANUVIA
Patent Number : 2450740
Filing Date : 2002-07-05
Strength per Unit : 100mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2022-07-05
Date Granted : 2006-02-14
Patent Expiration Date : 2022-07-05
Date Granted : 2006-02-14
sitagliptin phosphate monohydrate, metformin hydrochloride
Brand Name : JANUMET
Patent Number : 2450740
Filing Date : 2002-07-05
Strength per Unit : 50 mg / 500 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2022-07-05
Date Granted : 2006-02-14
Patent Expiration Date : 2024-06-18
Date Granted : 2007-10-09
sitagliptin phosphate monohydrate, metformin hydrochloride
Brand Name : JANUMET
Patent Number : 2529400
Filing Date : 2004-06-18
Strength per Unit : 50 mg / 500 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2024-06-18
Date Granted : 2007-10-09
Patent Expiration Date : 2022-07-05
Date Granted : 2006-02-14
sitagliptin phosphate monohydrate, metformin hydrochloride
Brand Name : JANUMET
Patent Number : 2450740
Filing Date : 2002-07-05
Strength per Unit : 50 mg / 850 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2022-07-05
Date Granted : 2006-02-14
Patent Expiration Date : 2022-07-05
Date Granted : 2006-02-14
sitagliptin phosphate monohydrate, metformin hydrochloride
Brand Name : JANUMET
Patent Number : 2450740
Filing Date : 2002-07-05
Strength per Unit : 50 mg / 1000 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2022-07-05
Date Granted : 2006-02-14
Patent Expiration Date : 2022-07-05
Date Granted : 2006-02-14
sitagliptin phosphate monohydrate
Brand Name : JANUVIA
Patent Number : 2450740
Filing Date : 2002-07-05
Strength per Unit : 25 mg
Dosage Form : Tablets
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2022-07-05
Date Granted : 2006-02-14
Patent Expiration Date : 2022-07-05
Date Granted : 2006-02-14
sitagliptin phosphate monohydrate
Brand Name : JANUVIA
Patent Number : 2450740
Filing Date : 2002-07-05
Strength per Unit : 50 mg
Dosage Form : Tablets
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2022-07-05
Date Granted : 2006-02-14
Patent Expiration Date : 2022-07-05
Date Granted : 2006-02-14
sitagliptin phosphate monohydrate, metformin hydrochloride
Brand Name : JANUMET XR
Patent Number : 2450740
Filing Date : 2002-07-05
Strength per Unit : 50 mg / 500 mg
Dosage Form : TABLET (EXTENDED-RELEASE)
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2022-07-05
Date Granted : 2006-02-14
Patent Expiration Date : 2022-07-05
Date Granted : 2006-02-14
sitagliptin phosphate monohydrate, metformin hydrochloride
Brand Name : JANUMET XR
Patent Number : 2450740
Filing Date : 2002-07-05
Strength per Unit : 50 mg / 1000 mg
Dosage Form : TABLET (EXTENDED-RELEASE)
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2022-07-05
Date Granted : 2006-02-14
Patent Expiration Date : 2022-07-05
Date Granted : 2006-02-14
sitagliptin phosphate monohydrate, metformin hydrochloride
Brand Name : JANUMET XR
Patent Number : 2450740
Filing Date : 2002-07-05
Strength per Unit : 100 mg / 1000 mg
Dosage Form : TABLET (EXTENDED-RELEASE)
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2022-07-05
Date Granted : 2006-02-14
